Corpus ID: 170076464

Pharmacologic vitreolysis of vitreous floaters by 3-month pineapple supplement in Taiwan : a pilot study

@inproceedings{Horng2019PharmacologicVO,
  title={Pharmacologic vitreolysis of vitreous floaters by 3-month pineapple supplement in Taiwan : a pilot study},
  author={Chi‐Ting Horng and Fu-An Chen and Daih Huang Kuo and Li-Chai Chen and Shou-Shan Yeh and Shuan-Yu Huang and Pochuen Shieh},
  year={2019}
}
Purpose: This survey is the first one in the world to evaluate the pharmacologic effects of pineapples for floaters. In different designs, we followed the results of patients who took various doses of pineapples each day for 3 months. Methods: The studies and sources of crude pineapples were all scheduled between March and June 2016 in Southern Taiwan, including Tainan, Kaohsiung and Ping­Tung Cities. The famous, beneficial and delicious pineapples were supplied by the local farmers selling to… Expand
2 Citations

Figures, Tables, and Topics from this paper

Treatment of Symptomatic Vitreous Opacities with Pharmacologic Vitreolysis Using a Mixure of Bromelain, Papain and Ficin Supplement
TLDR
It is demonstrated that mixed-fruit-enzyme including bromelain, papain and ficin may excise SVOs and even eliminate intraocular hemorrhage by cleaving the collagen fibrils and cellular debris that may induce ocular floaters. Expand
Vitreous and Vision Degrading Myodesopsia
  • J. Sebag
  • Medicine
  • Progress in Retinal and Eye Research
  • 2020
TLDR
Improved understanding of the underlying pathogenesis of Vision Degrading Myodesopsia should result in prevention, the ultimate goal of modern Medicine. Expand

References

SHOWING 1-10 OF 62 REFERENCES
Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials.
TLDR
Subgroup analyses confirmed the positive effect of ocriplasmin across relevant subpopulations of patients with symptomatic vitreomacular adhesion and VMT, including when associated with macular hole. Expand
Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters
TLDR
Patients’ symptoms from vitreous floaters are often underestimated resulting in no intervention and Nd:YAG vitreolysis is shown to be a safe but only moderately effective primary treatment conferring clinical benefit in one third of patients. Expand
Posterior vitreous detachment induced by microplasmin.
TLDR
Both after death and in vivo, microplasmin induces a dose-dependent cleavage between the vitreous cortex and the ILM without morphologic alterations of the retina in the feline eye. Expand
Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
TLDR
Ten eyes of nine patients were treated for very disturbing vitreous floaters with the technique of Nd-YAG laser vitreolysis, with the well- Suspended floaters responding better to treatment compared to the ill-suspended vitreOUS floaters. Expand
IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPY
TLDR
The angle between the posterior vitreous cortex and the internal limiting membrane correlates with VMT resolution and may be a clinically useful marker for selection of patients to be treated with ocriplasmin. Expand
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.
TLDR
Intravitreal injection of the vitreolytic agent ocriplasmin resolved vitreomacular traction and closed macular holes in significantly more patients than did injection of placebo and was associated with a higher incidence of ocular adverse events, which were mainly transient. Expand
Safety of vitrectomy for floaters.
TLDR
The risk profile of vit rectomy for floaters is comparable with that of vitrectomy for other elective indications and patients considering surgery for floater should be informed specifically about the risks involved. Expand
Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment.
TLDR
The prompt and conscientious vitreoretinal examination of each patient older than 45 years of age who experiences vitreous floaters, even though limited to one or two, should be undertaken without delay, to provide the most effective known means of preventing rhegmatogenous retinal detachment. Expand
Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review
TLDR
The available evidence-base of treatment options available for SVO is summarised with special emphasis on the safety and efficacy of vitrectomy for this condition. Expand
Symptoms and findings predictive for the development of new retinal breaks.
TLDR
Follow-up visits are only necessary if patients mention symptoms of flashes in combination with multiple floaters or a curtain or cloud at the initial examination, or an increase in number of floaters after theInitial examination. Expand
...
1
2
3
4
5
...